A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

Clinical trial NCT03329508 · COMPLETED

Trial details

NCT number: NCT03329508
Sponsor: Pharma Two B Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease Early Parkinson's Disease

Start date: 2018-01-19
Primary completion: 2021-08-23
Enrollment: 544

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.